European Endocrinology Volume 13 - Issue 2 - Autumn 2017

We are delighted to welcome you to the Autumn edition of European Endocrinology, which includes a wide selection of diabetes content to coincide with the EASD 2017.

This edition includes two articles series for you to enjoy. The first explores the development of DPP-4 inhibitors, including vildagliptin, and how the treatment landscape has evolved since research began 25 years ago. The second series focuses on continuous glucose monitoring, and evaluates how it is been adopted within the UK. Further articles on diabetic macular oedema, diabetes pathophysiology and hyperthyroidism are also included for you to enjoy.

We hope you enjoy these articles, along with the multimedia content you will find accompanying many of the articles in this edition.

Thank you to all of our contributing authors. Our Editor-in-Chief Abd Tahrani would like to welcome all members of the endocrinology community to submit articles to our Spring 2018 edition. Read our call for submissions for more information, and visit our submission system if you have a paper to submit.

Foreword

Letter from the Editor-in-Chief

Pathogenesis of Type 2 Diabetes

Type 2 Diabetes

Continuous Glucose Monitoring

Cardiovascular Risk

Diabetic Macular Edema

Hyperthyroidism